NKGen Biotech

GFOR

GFOR NKGen Biotech NYSE
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    GFOR Chart
    See on advanced chart >

    About

    NKGen Biotech, Inc.is a clinical-stage biotechnology company incorporated as a Delaware corporation developing cell therapies for neurodegenerative and oncological diseases based on activated natural killer ("NK") cells. NKGen's product candidates are based...
    • Highlight
      A clinical-stage biotechnology company focused on autologous, allogeneic and CAR-NK natural killer cell therapies
    • Industry
    • Exchange
      NYSE
    • Listing Date
      07/13/2021
    • Established Date
      Invalid Date
    • Full-time Employees
      67
    • Address
      3001 Daimler St Santa Ana California 92705
    • Tel
      1-949-3966830
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock
    cache time: 2024-04-21 19:09:43